Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

SHE/300636 stock hub

SHE/300636 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHE/300636is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

3.3B

Shenzhen Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHE/300636

In the news

Latest news · SHE/300636

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 17.1P50 24.2P75 37.8

Trailing P/E46.3

P25 23.5P50 41.3P75 83.2

ROE3

P25 -0.9P50 4.1P75 8.8

ROIC4.9

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHE/300636 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

223

Groups with data

Currency

CNY

Showing 223 of 223 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	1,418
Employees Change	56%
Employees Change Percent	4.11
Enterprise value	CNY 3.2B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CNE100002P83
Last refreshed	2026-05-10
Market cap	CNY 3.3B
Price	CNY 7.84
Price currency	CNY
Rev Per Employee	582,619.52x
Sector	Healthcare
Sic	2834
Symbol	she/300636
Website	https://www.jxsynergy.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.16%
EV Earnings	45.41x
EV/EBIT	25.7x
EV/EBITDA	12.38x
EV/FCF	-34.5x
EV/Sales	3.91x
FCF yield	-2.84%
P/B ratio	1.38x
P/E ratio	46.33x
P/S ratio	3.99x
PE Ratio10 Y	46.27x
PE Ratio3 Y	37.53x
PE Ratio5 Y	43.46x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	15.21%
EBITDA Margin	31.48%
Gross margin	30.48%
Gross Profit	CNY 251.8M
Gross Profit Growth	11.24%
Gross Profit Growth Q	2.13%
Gross Profit Growth3 Y	0.23%
Gross Profit Growth5 Y	10.31%
Net Income	CNY 71.1M
Net Income Growth	-15.17%
Net Income Growth Q	-9.63%
Net Income Growth Years	0%
Net Income Growth3 Y	-12.72%
Net Income Growth5 Y	-0.91%
Pretax Margin	8.85%
Profit Margin	8.6%
Profit Per Employee	CNY 50,134
Profitable Years	14
ROA	2.33
Roa5y	2.57
ROCE	4.98
ROE	3.02
Roe5y	6.49
ROIC	4.86
Roic5y	4.91

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	8.42%
Cagr3y	-15.59%
Cagr5y	-6.28%
Div CAGR3	-12.64%
Div CAGR5	-6.59%
EPS Growth	-15.22
EPS Growth Q	-9.7
EPS Growth Years	0
EPS Growth3 Y	-17.9
EPS Growth5 Y	-6.79
OCF Growth	-35.12%
OCF Growth Q	-37.02%
OCF Growth10 Y	7.64%
OCF Growth3 Y	0.72%
OCF Growth5 Y	16.19%
Revenue Growth	11.74x
Revenue Growth Q	-1.34x
Revenue Growth Years	7x
Revenue Growth3 Y	2.78x
Revenue Growth5 Y	11.65x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.25
Assets	CNY 3.3B
Cash	CNY 274.4M
Current Assets	CNY 1.4B
Current Liabilities	CNY 787.9M
Debt	CNY 210.2M
Debt EBITDA	CNY 0.81
Debt Equity	CNY 0.09
Debt FCF	CNY -2.25
Equity	CNY 2.4B
Liabilities	CNY 927.6M
Long Term Assets	CNY 1.9B
Long Term Liabilities	CNY 139.7M
Net Cash	CNY 64.2M
Net Cash By Market Cap	CNY 1.95
Net Debt EBITDA	CNY -0.25
Net Debt Equity	CNY -0.03
Tangible Book Value	CNY 2.4B
Tangible Book Value Per Share	CNY 5.63
WACC	5.61

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.82
Inventory Turnover	1.06
Net Working Capital	CNY 542.8M
Quick ratio	0.52
Working Capital	CNY 645.9M
Working Capital Turnover	CNY 1.35

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.06%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	CNY 0.04
Dividend Years	8
Dividend Yield	0.51%
Ex Div Date	2025-06-27
Last Dividend	CNY 0.04
Payout Frequency	Annual
Payout Ratio	39.18%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	8.42%
200-day SMA	8.24
3Y total return	-39.86%
50-day SMA	8.01
50-day SMA vs 200-day SMA	50under200
5Y total return	-27.7%
All Time High	26.17
All Time High Change	-70.04%
All Time High Date	2022-05-12
All Time Low	4.07
All Time Low Change	92.63%
All Time Low Date	2018-10-19
ATR	0.22
Beta	0.31
Beta1y	0.28
Beta2y	0.65
Ch YTD	4.39
High	7.85
High52	9.48
High52 Date	2025-09-09
High52ch	-17.3%
Low	7.68
Low52	7.17
Low52 Date	2026-03-23
Low52ch	9.34%
Ma50ch	-2.15%
Price vs 200-day SMA	-4.84%
RSI	46.35
RSI Monthly	43.89
RSI Weekly	44.74
Sharpe ratio	0.3x
Sortino ratio	0.66
Total Return	0.45%
Tr YTD	4.39
Tr1m	-4.04%
Tr1w	1.16%
Tr3m	-4.85%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 125.6M
Operating Income Growth	31.2
Operating Income Growth Q	-4.1
Operating Income Growth3 Y	0.68
Operating Income Growth5 Y	7.84
Operating margin	15.21

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	282,884,569%
Net Borrowing	-172,404,797
Shares Insiders	31.88%
Shares Institutions	5.38%
Shares Out	419,951,495
Shares Qo Q	-0.03%
Shares Yo Y	0.06%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY -93.6M
Average Volume	7,164,155.7x
Bv Per Share	5.67
CAPEX	CNY -282.4M
Ch1m	-4.04
Ch1w	1.16
Ch1y	7.84
Ch3m	-4.85
Ch3y	-40.61
Ch5y	-29
Ch6m	-4.51
Change	1.95%
Change From Open	2.08
Close	7.69
Days Gap	-0.13
Depreciation Amortization	134,466,752
Dollar Volume	57,257,832.8
Earnings Date	2026-04-29
EBIT	CNY 125.6M
EBITDA	CNY 260.1M
EPS	CNY 0.17
F Score	6
FCF	CNY -93.6M
FCF EV Yield	-2.9x
FCF Per Share	CNY -0.22
Financing CF	-203,624,920
Fiscal Year End	December
Founded	2,004
Graham Number	4.64796
Graham Upside	-40.71
Income Tax	CNY 2.1M
Investing CF	-166,918,904
Is Primary Listing	1
Last Earnings Date	2026-04-29
Last Report Date	2026-03-31
Last Split Date	2022-07-05
Last Split Type	Forward
Lynch Fair Value	CNY 0.85
Lynch Upside	-89.21
Ma150	8.13
Ma150ch	-3.56%
Ma20	7.97
Ma20ch	-1.67%
Net CF	-185,967,779
Next Earnings Date	2026-08-28
Open	7.68
P OCF Ratio	17.43
Payment Date	2025-06-27
Position In Range	94.12
Ppne	1,751,545,430
Price Date	2026-05-08
Price EBITDA	CNY 12.66
Ptbv Ratio	1.39
Relative Volume	1.04x
Revenue	826,154,474x
Tax By Revenue	0.25x
Tax Rate	2.81%
Tr6m	-4.51%
Volume	7,303,295

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHE/300636 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.5%

$0.04 annual per share

Payout ratio

+39.2%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-6.6%

0 consecutive years of growth

Total shareholder yield

+0.5%

Next ex-dividend date: 2025-06-27

Performance

SHE/300636 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHE/300636?

Insider, institutional, and short-interest positioning.

Institutional ownership

+5.4%

Share of float held by funds and institutions

Insider ownership

+31.9%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.1%

Negative means the company is buying back shares.

Technical

SHE/300636 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

46.3

Neutral momentum band

Price vs 200-day MA

-4.8%

50/200-day relationship not available

Beta (5Y)

0.31

Less volatile than the market

Sharpe ratio

0.30

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHE/300636

Hub-level FAQ points readers to the deeper analysis pages.

What is the current she/300636 stock rating?

she/300636 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full she/300636 analysis?

The full report lives at /stocks/she/300636/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for she/300636?

The latest report frames she/300636 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the she/300636 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.